BioCentury | Jun 7, 2017
Distillery Therapeutics

Cancer

...HER1), to treat colorectal cancer and head and neck cancer. Critical Outcome Technologies Inc. has COTI-219...
BioCentury | May 31, 2017
Distillery Therapeutics

Pulmonary

...Spiegelmer technology, in Phase I testing to treat solid tumors. Critical Outcome Technologies Inc. has COTI-219...
Items per page:
1 - 2 of 2